Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DUSP12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | PKLR | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | IRX3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | GMIP | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
mRNA | PPP1R2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | PKD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | RPS5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | C22orf39 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | EMC6 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | GPKOW | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |